Damora Therapeutics logo
Damora Therapeutics
DMRA | NASDAQ
Chart Builder DCF Calculator
$22.50
+$0.90 (+4.17%)
At close: Nov 16, 2026, 4:00 PM ET
$22.06
-$0.44 (-1.96%)
After-hours: Nov 16, 2026, 7:30 PM ET

Damora Therapeutics Company Profile

Company profile explained

Company Profile

Damora Therapeutics, Inc., a biopharmaceutical company, develops therapies for the treatment of hematologic disorders in Denmark and North America. The company’s lead product includes DMR-001, a investigational monoclonal antibody therapy that targets mutations in CALR, for the treatment of essential thrombocythemia; and DMR-002 and DMR-003, both anti-mutCALR-based therapies, with the intent to ultimately address the full spectrum of mutCALR MPN patients. It also develops GB3226, a small molecule inhibitor of ENL-YEATS and FLT3 for the treatment of acute myeloid leukemia. Damora Therapeutics, Inc. was founded in 2011 and is headquartered in Waltham, Massachusetts.

Key Executives

Name Position
Jennifer A. Jarrett CEO, President & Director
Sherwin Sattarzadeh Chief Operating Officer
Becker Hewes Chief Medical Officer
Brian Burkavage Senior VP of Finance, Principal Financial & Accounting Officer
Garrett Winslow Senior VP, General Counsel & Corporate Secretary
Hakon Leffler Co-Founder
Tariq Sethi FRCP Co-Founder
Ulf J. Nilsson Co-Founder

Latest SEC Filings

No SEC filings available
View All SEC Filings ➞
Damora Therapeutics
Damora Therapeutics logo
Country United States
IPO Date Oct 29, 2020
Industry Biotechnology
Sector Healthcare
Employees 7
CEO Jennifer A. Jarrett

Contact Details

Building 23 Waltham, Massachusetts 02453 United States

Stock Details

Ticker Symbol DMRA
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001800315
CUSIP Number G2646Y104
ISIN Number KYG2646Y1044
SIC Code 2834

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.